ABBV
AbbVie Inc.
AbbVie Inc. is a pharmaceutical company with significant political exposure through $156.4M in annual physician payments and direct holdings by the executive branch, but minimal recent lobbying or insider buying.
Govt Dependence
20/100
Regulatory Density
85/100
Lobbying Intensity
0/100
Political Signal
NEUTRAL
BusinessWhat ABBV does
AbbVie is a research-based biopharmaceutical company. Its revenue is derived from a portfolio of products, including immunology, oncology, neuroscience, and aesthetics. The company operates globally, with key products like Humira, Skyrizi, and Rinvoq.
6 months past · 3 months futureABBV activity timeline
Congress
buy
sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened
+ added
− trimmed
closed
holds
Bills
past action (this ticker)
upcoming markup (sector)
★ carveout (this ticker)
113 trading days ·
5 congressional trades shown
·
0 insider buys
·
3 13F filings
·
0 past bill actions
·
16 upcoming markups
Executive Branch ConflictsABBV held by Trump-administration officials
1 cabinet/senior official reported ABBV positions in OGE Form 278 disclosures across 4 filings.
Lifetime Government AwardsABBV federal contracts
ABBV doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding ABBV
$8.89B
Total ABBV held by tracked 13F funds
40
Funds with ABBV positions
+40
Funds opened this quarter
Citadel Advisors
$689M
opened
2025-09-30
Citadel Advisors
$554M
opened
2025-06-30
Citadel Advisors
$550M
opened
2025-03-31
Citadel Advisors
$487M
opened
2024-09-30
Millennium Management
$467M
opened
2025-09-30
Citadel Advisors
$465M
opened
11 overlap
2025-12-31
Citadel Advisors
$457M
opened
2024-03-31
Millennium Management
$454M
opened
2025-06-30
32 more 13F positions tracked · quarterly delta charts available in member dashboard
Politicians Trading ABBVMembers of Congress with recent ABBV positions
13 politicians traded ABBV across 88 disclosed transactions totaling $1.1M (last 730 days).
Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just ABBV). 0-30 LOW · 30-60 MID · 60+ HIGH.
Ro Khanna
19 buys
13 sells
$428K
2026-01-29
LOW · 0
Jefferson Shreve
2 buys
2 sells
$300K
2025-04-17
LOW · 0
Lisa C. McClain
6 buys
6 sells
$96K
2025-10-31
LOW · 0
Josh Gottheimer
6 buys
2 sells
$64K
2025-05-22
LOW · 1
Robert P. Bresnahan
4 buys
2 sells
$48K
2025-05-15
LOW · 0
Ritchie Torres
2 buys
2 sells
$32K
2025-07-11
LOW · 0
Julie Johnson
4 sells
$32K
2025-12-18
LOW · 15
Julia Letlow
2 buys
2 sells
$32K
2025-12-08
LOW · 1
Jared Moskowitz
4 buys
$32K
2025-04-07
LOW · 0
John Boozman
4 sells
$32K
2025-08-22
MID · 47
John James
2 sells
$16K
2024-09-04
LOW · 0
Dwight Evans
2 sells
$16K
2025-04-03
LOW · 0
Virginia Foxx
2 buys
$16K
2024-12-06
LOW · 1
Congressional TradesWho in Congress is trading ABBV
2026-01-23
Ro Khanna
Purchase
$1,001 - $15,000
2026-01-29
Ro Khanna
Sale
$15,001 - $50,000
2025-12-18
Julie Johnson
Sale
$1,001 - $15,000
2025-04-28
Julia Letlow
Purchase
$1,001 - $15,000
260d late
2024-10-23
Julia Letlow
Purchase
$1,001 - $15,000
447d late
2025-01-24
Julia Letlow
Sale
$1,001 - $15,000
354d late
2025-12-08
Julia Letlow
Sale
$1,001 - $15,000
2025-11-13
Julie Johnson
Sale
$1,001 - $15,000
2025-10-31
Lisa C. McClain
sale
$1,001 - $15,000
2025-10-30
Lisa C. McClain
purchase
$1,001 - $15,000
2025-10-30
Lisa C. McClain
Purchase
$1,001 - $15,000
2025-10-30
Lisa C. McClain
sale
$1,001 - $15,000
30+ trades on file · most recent 2026-02-06
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
Stock awards & option exercises
92
stock awards · $210.6M market value
3
option exercises · $3.9M
2026-03-31
RAPP EDWARD J
Director
AWARD
155 sh
$34K
2026-03-31
Quaggin Susan E
Director
AWARD
71 sh
$15K
2026-03-31
Alpern Robert J
Director
AWARD
35 sh
$8K
2026-02-18
Michael Robert A.
CHIEF EXECUTIVE OFFICER
AWARD
81,251 sh
$18.7M
2026-02-18
Michael Robert A.
CHIEF EXECUTIVE OFFICER
AWARD
33,833 sh
$7.7M
2026-02-18
Michael Robert A.
CHIEF EXECUTIVE OFFICER
AWARD
33,833 sh
$7.7M
2026-02-18
Stewart Jeffrey Ryan
EVP, CHIEF COMMERCIAL OFFICER
AWARD
26,812 sh
$6.2M
2026-02-18
Stewart Jeffrey Ryan
EVP, CHIEF COMMERCIAL OFFICER
AWARD
26,063 sh
$6.0M
For ABBV, executives receive stock primarily as compensation rather than via open-market purchases — typical for established large-cap firms.
Bills Affecting ABBVLive legislation impacting this stock
HR.1860 · 119th
Women Veterans Cancer Care Coordination Act
HR.1875 · 119th
Medicaid Provider Screening Accountability Act
HR.1867 · 119th
To amend title XVIII of the Social Security Act to remove in-person requirements under Medicare for mental health services furnish
HR.1843 · 119th
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
HRES.185 · 119th
Recognizing the need of Congress to prevent, address, and treat obesity as a disease in the United States on this World Obesity Da
HRES.182 · 119th
Expressing support for the designation of March 3, 2025, as "National Triple-Negative Breast Cancer Day".
HR.1806 · 119th
Triple-Negative Breast Cancer Research and Education Act of 2025
S.786 · 119th
Public Health Funding Restoration Act
S.763 · 119th
Telehealth Expansion Act of 2025
SRES.90 · 118th
A resolution recognizing the significance of endometriosis as an unmet chronic disease for women and designating March 2023 as "En
Political ProfileWhere ABBV sits in Washington
[object Object]
STRUCTURAL: Strong Democratic donation alignment (100% of $31K) and two recipients on tax-writing Ways and Means committee. EVIDENTIARY: Zero corporate insider buys in 180 days (`get_corporate_insider_signal.total_buys: 0`), zero federal contracts, and mixed congressional trading with net sales. Net: High regulatory density offset by weak transactional signals.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Heightened scrutiny of physician payment practicesHHS/CMS"`get_political_influence.doctor_payments` shows $156.4M in payments to physicians in 2024."
Regulatory opportunities
- No specific regulatory opportunities flagged.
Capitol Hill AlliesChampions & critics
Congressional champions
Congressional critics
- No specific congressional critics identified.
Member intelligence layer
Live signals + predictions for ABBV — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades ABBV
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord
Frequently AskedAbout ABBV & political exposure
Does AbbVie Inc. (ABBV) hold federal contracts?
No direct prime contracts reported in USASpending.gov for AbbVie Inc.. Companies in the semiconductor and AI hardware sectors often sell to the federal government via prime contractors and cloud resellers (Microsoft Azure, AWS, Lockheed Martin systems integration) rather than as direct primes.
Which Trump cabinet officials own ABBV stock?
1 Trump cabinet members or senior White House staff have disclosed holdings in ABBV on their OGE 278 financial disclosures, including Donald J. Trump. See the Cabinet Conflicts panel for details.
Has Congress traded ABBV stock?
478 congressional trades by 55 unique members of Congress, most recently on 2026-01-29. See the Congressional Trading panel for politician-by-politician breakdown.
What is ABBV political risk profile?
Government dependence: 20/100. Lobbying intensity: 0/100. Political signal: neutral. Donor party split: R 0% / D 100%.
How does GovGreed track ABBV political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. ABBV data is updated daily from these official federal sources.